Cronos Group Inc. (7CI)
FSX
Closed
Oct 9, 2026
Day's Range
2.8352 wk Range
1.96Overview - 7CI - Cronos Group Inc.
Key Statistics
Valuation
Enterprise Value
274.29M
P/E (Trailing)
‪16.89‬
PEG Ratio
‪-0.08‬
Price / Sales (TTM)
‪5.90‬
Price / Book
‪1.12‬
EV / EBITDA
‪26.19‬
Profitability
Gross Margin
‪53.67%‬
Profit Margin
‪39.07%‬
Operating Margin
‪15.44%‬
Return on Assets
‪-0.09%‬
Return on Equity
‪7.04%‬
Ownership
Shares Outstanding
370.72M
Float
186.98M
Held by Insiders
‪49.14%‬
Held by Institutions
‪15.47%‬
Price stats
Beta
‪1.27‬
50-Day Avg
‪2.72‬
200-Day Avg
‪2.37‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 7CI - Cronos Group Inc.
Peers - 7CI - Cronos Group Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
Profile Summary - 7CI - Cronos Group Inc.
About
Cronos Group Inc. is a cannabinoid company focused on the cultivation, production, distribution, and marketing of cannabis products. The company serves adult-use and medical cannabis markets in Canada and Israel, while also reaching international customers through a portfolio of branded products. Its offerings include…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
